Prognostic Value of -Pertechnetate Thyroid Scintigraphy in Radioiodine Therapy in a Cohort of Chinese Graves’ Disease Patients: A Pilot Clinical Study

Table 2

Comparative analysis on pre-RIT variables in different groups.

Variables	Patients group with different outcome of RIT
	Hypothyroidism and euthyroidism ()	Hyperthyroidism ()
Age (years)	39.83 ± 12.88	41.62 ± 12.32	0.377
Disease duration (years)	4.37 ± 5.27	3.77 ± 3.40	0.631
Hormone levels
FT4 (pmol/L)	54.20 ± 26.26	59.17 ± 29.47	0.463
FT3 (pmol/L)	19.44 ± 7.43	21.35 ± 7.09	0.152
TT4 (nmol/L)	255.46 ± 77.06	273.37 ± 86.95	0.470
TT3 (nmol/L)	6.80 ± 2.92	7.75 ± 3.09	0.048
Thyroid mass (g)	38.28 ± 7.34	48.18 ± 8.41	<0.001
^99mTc-pertechnetate uptake (%)	12.83 ± 6.05	21.19 ± 7.80	<0.001